搜索
Virax Biolabs Group Ltd
VRAX添加自选
2.620USD
-0.180-6.43%
收盘 07-31 16:00（美东）报价延迟15分钟
11.38M总市值
亏损市盈率 TTM
关于 Virax Biolabs Group Ltd 公司
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Virax Biolabs Group Ltd简介
公司代码VRAX
公司名称Virax Biolabs Group Ltd
上市日期Jul 14, 2022
CEOFoster (James)
员工数量19
证券类型Ordinary Share
年结日Jul 14
公司地址Biocity Glasgow
城市LONDON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United Kingdom
邮编ML1 5UH
电话4402077887414
网址https://www.viraxbiolabs.com
公司代码VRAX
上市日期Jul 14, 2022
CEOFoster (James)
Virax Biolabs Group Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
常见问题
Virax Biolabs Group Ltd的前五大股东是谁？
Virax Biolabs Group Ltd 的前五大股东如下：Mr. James Foster
有多少机构持有Virax Biolabs Group Ltd(VRAX)的股份？
截至2026Q1，共有22家机构持有Virax Biolabs Group Ltd的股份，合计持有的股份价值约为851.39K，占公司总股份的4.27%。与2025Q4相比，机构持股有所增加，增幅为268600.00。